Loading
CP
CoLucid Pharmaceuticals, Inc. Stock: price and insider trades · United States
CoLucid Pharmaceuticals, Inc.: what insiders have been doing
CoLucid Pharmaceuticals, Inc. is a listed company. Filings by its managers are published through SEC (Form 4). The past year has been quiet: not a single insider filing for CoLucid Pharmaceuticals, Inc. The previous disclosure was published on 1 March 2017.
Since 2016, the database holds no purchases and 37 sales by insiders of the company.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
67
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€2M
37 ops. · all time
Last declaration on 1 March 2017
Declarations67 total
1,871,049 shares@ US$46.50Common StockSEC:0000911916-17-000086:0
116,317 shares@ US$46.50Common StockSEC:0000911916-17-000086:1
5,528 shares@ US$46.50Common StockSEC:0000911916-17-000086:2
19,285,108 shares@ US$46.50Common Stock, par value $0.001SEC:0000899243-17-005803:0
1,545,386 shares@ US$46.50Common StockSEC:0000911916-17-000076:0
2,708 shares@ US$46.50Common StockSEC:0000911916-17-000068:0
37,500 shares@ US$46.50Common StockSEC:0000911916-17-000068:1
3,615 shares@ US$46.50Common StockSEC:0000911916-17-000081:0
173,519 shares@ US$46.50Common StockSEC:0000911916-17-000078:0
83,000 shares@ US$46.50Common StockSEC:0000911916-17-000078:1
2,729 shares@ US$46.50Common StockSEC:0000911916-17-000072:0
37,500 shares@ US$46.50Common StockSEC:0000911916-17-000072:1
718 shares@ US$6.75Common StockSEC:0000911916-17-000032:0
718 shares@ US$36.25Common StockSEC:0000911916-17-000032:1
185 shares@ US$7.56Common StockSEC:0000911916-17-000032:2
185 shares@ US$36.40Common StockSEC:0000911916-17-000032:3
1,677 shares@ US$10.00Common StockSEC:0000911916-17-000032:4
477 shares@ US$33.55Common StockSEC:0000911916-17-000032:5
600 shares@ US$34.40Common StockSEC:0000911916-17-000032:6
600 shares@ US$35.61Common StockSEC:0000911916-17-000032:7
3,755 sharesCommon StockSEC:0000911916-17-000034:0
802 shares@ US$34.25Common StockSEC:0000911916-17-000034:1
200 shares@ US$34.86Common StockSEC:0000911916-17-000034:2
500 shares@ US$35.60Common StockSEC:0000911916-17-000034:3
1,473 shares@ US$36.25Common StockSEC:0000911916-17-000026:0
25 of 67 declarations
About CoLucid Pharmaceuticals, Inc.
CoLucid Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing treatments for migraines. It is listed on NASDAQ under the symbol CLCD.
